ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells

A new research paper was published in Oncotarget’s Volume 15 on March 14, 2024, entitled, “ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.”

FDA approves Takeda’s GAMMAGARD LIQUID for CIDP treatment

Share this article The FDA granted the approval based on data from Takeda’s ADVANCE-CIDP 2 clinical trial of GAMMAGARD LIQUID. Credit: Jonathan Weiss / Shutterstock.com.

January 30, 2024

Canada Is Down Not Out

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

April 19, 2024

Cannabis Sales Remain Soft in Canada

Statistics Canada released December retail sales for the country, with cannabis sales increasing from the weak November levels, up 8.2% to C$441.2 million. October was revised lower to

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.